SCHEMBL1269946

SCHEMBL1269946

CCNS(=O)(=O)c1ccc(Sc2ccc(NS(=O)(=O)c3ccc(Cl)cc3Cl)nc2C(=O)C2CC2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGDR2 Q9Y5Y4 2/20 0.40
▸ PTGDR Q13258 1/20 0.40
▸ ALDH1A1 P00352 2/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ HSD11B1 P28845 1/20 0.35
▸ THRB P10828 1/20 0.34
▸ PIK3C3 Q8NEB9 2/20 0.34
▸ FLT1 P17948 1/20 0.34
▸ FLT4 P35916 1/20 0.34
▸ KDR P35968 1/20 0.34
▸ PPARG P37231 4/20 0.34
▸ PPARD Q03181 3/20 0.34
▸ PPARA Q07869 3/20 0.34
▸ LMNA P02545 1/20 0.33
▸ CCR4 P51679 1/20 0.33
▸ PKM P14618 1/20 0.33
▸ STARD7 Q9NQZ5 1/20 0.33
▸ PCTP Q9UKL6 1/20 0.33
▸ STARD10 Q9Y365 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1269951 0.91 PTGDR2 (0.41) PTGDR2PTGDRALDH1A1HSD11B1PIK3C3
SCHEMBL1269586 0.90 PIK3C3 (0.38) PTGDR2PTGDRALDH1A1MAPTHSD11B1
SCHEMBL1269518 0.89 PTGDR (0.39) PTGDR2PTGDRALDH1A1MAPTHSD11B1
SCHEMBL1269948 0.88 PTGDR (0.38) PTGDR2PTGDRHSD11B1PIK3C3FLT1
SCHEMBL1269748 0.87 PTGDR2 (0.43) PTGDR2PTGDRALDH1A1NPC1MAPT
SCHEMBL1268967 0.86 PTGDR (0.36) PTGDR2PTGDRHSD11B1PIK3C3FLT1
SCHEMBL1269493 0.85 HTT (0.38) PTGDR2PTGDRALDH1A1MAPTLMNA
SCHEMBL1269665 0.85 HTT (0.40) ALDH1A1NPC1MAPTLMNAPOLB
SCHEMBL1268682 0.83 KMT2A (0.43) ALDH1A1NPC1MAPTLMNAPOLB
SCHEMBL1268610 0.79 SMN1; SMN2 (0.37) PTGDR2PTGDRALDH1A1MAPTPIK3C3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7893077-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2011-02-22 — — US disclosed
US-7893077-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2011-02-22 — — US disclosed
US-7893077-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2011-02-22 — — US disclosed
EP-1786782-B1 BISARYL-SULFONAMIDES AMGEN INC (US) 2010-03-31 — — EP disclosed
EP-1786782-B1 BISARYL-SULFONAMIDES AMGEN INC (US) 2010-03-31 — — EP disclosed
US-20090221584-A1 Bisaryl-sulfonamides AMGEN INC. 2009-09-03 — — US disclosed
US-20090221584-A1 Bisaryl-sulfonamides AMGEN INC. 2009-09-03 — — US disclosed
US-20090221584-A1 Bisaryl-sulfonamides AMGEN INC. 2009-09-03 — — US disclosed
US-7544702-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2009-06-09 — — US disclosed
US-7544702-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2009-06-09 — — US disclosed
US-7544702-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2009-06-09 — — US disclosed
US-20060084802-A1 Bisaryl-sulfonamides AMGEN INC. 2006-04-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090221584-A1 Bisaryl-sulfonamides PPARD, PPARA, PPARG PTGDR2 649/4885PTGDR 709/4885ALDH1A1 2237/4885
US-20060084802-A1 Bisaryl-sulfonamides PPARD, PPARA, PPARG PTGDR2 649/4885PTGDR 709/4885ALDH1A1 2237/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback